The DOI matches its Crossref record.
Acetylation Rates and Monthly Liver Function Tests during One Year of Isoniazid Preventive Therapy
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“transient and self‐limited aminotransferase elevations encountered with drugs like isoniazid and statins (Figure 2) that can resolve with continued dosing, presumably because of metabolic and or immunological adaptation.177,178”
From AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury (2023) · cites this paper as [177]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 36
- Randolph, 1953, Toxic hepatitis with jaundice occurring in a patient treated with isoniazid, JAMA, 152, 38, 10.1001/jama.1953.63690010014007i · doi:10.1001/jama.1953.63690010014007i
- Gellis, 1955, Hepatitis following isoniazid, Dis Chest, 28, 462, 10.1378/chest.28.4.462 · doi:10.1378/chest.28.4.462
- Merritt, 1959, Toxic hepatic necrosis (hepatitis) due to isoniazid: Report of a case with cirrhosis and death due to hemorrhage from esophageal varices, Ann Intern Med, 50, 804, 10.7326/0003-4819-50-3-804 · doi:10.7326/0003-4819-50-3-804
- Haber, 1959, Icterus and febrile reactions in response to isonicotinic acid hydrazine, N Engl J Med, 260, 417, 10.1056/NEJM195902262600904 · doi:10.1056/nejm195902262600904
- Gillis, 1960, Unusual reactions to antituberculous chemotherapy, Med J Aust, 2, 99, 10.5694/j.1326-5377.1960.tb87016.x · doi:10.5694/j.1326-5377.1960.tb87016.x
- Cohen, 1961, Fatal hepatic necrosis secondary to isoniazid therapy, JAMA, 176, 877, 10.1001/jama.1961.63040230013013b · doi:10.1001/jama.1961.63040230013013b
- Davies, 1961, Jaundice due to isoniazid, Tubercle, 42, 504, 10.1016/S0041-3879(61)80140-2 · doi:10.1016/s0041-3879(61)80140-2
- Assem, 1969, Liver damage and isoniazid allergy, Clin Exp Immunol, 5, 439
- Ferebee, 1969, Controlled chemoprophylaxis trials in tuberculosis. A general review, Adv Tuberc Res, 17, 28
- Scharer, 1969, Serum transaminase elevations and other hepatic abnormalities in patients receiving isoniazid, Ann Intern Med, 71, 1113, 10.7326/0003-4819-71-6-1113 · DOI
- Martin, 1970, Hepatitis after isoniazid administration, N Engl J Med, 282, 433, 10.1056/NEJM197002192820808 · doi:10.1056/nejm197002192820808
- Garibaldi, 1972, Isoniazid-associated hepatitis. Report of an outbreak, Am Rev Resp Dis, 106, 357, 10.1164/arrd.1972.106.3.357 · DOI · Paper page
- 1971, Report of the Ad Hoc Committee on Isoniazid and Liver Disease, Center for Disease Control, Department of Health, Education, and Welfare, March 17-18, 1971: Isoniazid and liver disease, Am Rev Resp Dis, 104, 454, 10.1164/arrd.1971.104.3.454 · doi:10.1164/arrd.1971.104.3.454
- Wijsmuller, 1972, The use of the Mantoux test in identifying high-risk groups in a mental institution, Chest, 62, 565, 10.1378/chest.62.5.565 · doi:10.1378/chest.62.5.565
- Mosley, 1965, Stability of serum-glutamic pyruvic transaminase activity on storage, Techn Bull Regist Med Techn, 35, 183
- Keffer, 1971, Fluorescent antinuclear antibody test, Clin Lab Forum, 2, 1
- Green, 1969, The effect of the amount of mycobacterial adjuvants on the immune response of strain 2, strain 13, and Hartley strain guinea pigs to DNP-PLL and DNP-GL, J Immunol, 103, 403, 10.4049/jimmunol.103.3.403 · doi:10.4049/jimmunol.103.3.403
- Ellman, 1971, Strain difference in the immune response to hydralazine in inbred guinea pigs, Clin Exp Immunol, 9, 927
- Ellard, 1972, The determination of isoniazid and its metabolites acetylisoniazid, mono-acetylhydrazine, diacetylhydrazine, isonicotinic acid and isonicotinylglycine in serum and urine, Biochem J, 126, 449, 10.1042/bj1260449 · doi:10.1042/bj1260449
- Belles, 1962, A sensitive filter paper spot test for the detection if isoniazid (INH) metabolites in urine, Med J Aust, 2, 588, 10.5694/j.1326-5377.1962.tb20587.x · doi:10.5694/j.1326-5377.1962.tb20587.x
- Byrd, 1972, Isoniazid toxicity. A prospective study in secondary chemoprophylaxis, JAMA, 220, 1471, 10.1001/jama.1972.03200110051009 · doi:10.1001/jama.1972.03200110051009
- Bailey, 1973, Disturbed hepatic function during isoniazid chemoprophylaxis, Am Rev Resp Dis, 107, 523, 10.1164/arrd.1973.107.4.523 · doi:10.1164/arrd.1973.107.4.523
- 1974, A joint statement of the American Thoracic Society, American Lung Association, and the Center for Disease Control. Preventive therapy of tuberculous infection, Am Rev Resp Dis, 110, 371
- Hughes, 1955, The metabolism of isoniazid. Its implications in therapeutic use, Trans 14th Conf Chemotherap Tuberc, 217
- Recknagle, 1973, Carbon tetracholoride hepatotoxicity. An example of lethal cleavage, CRC Crit Rev in Toxicol, 263
- Black, 1973, Isoniazid-associated hepatic disease, Gastroenterology, 65, 528
- Maddrey, 1973, Isoniazid hepatitis, Ann Intern Med, 79, 1, 10.7326/0003-4819-79-1-1 · DOI · Paper page
- Adriany, 1960, Toxicity to para-aminosalicylic acid and isoniazid, Dis Chest, 38, 107, 10.1378/chest.38.1.107 · doi:10.1378/chest.38.1.107
- Alarcon-Segovia, 1971, Isoniazid acetylation rate and development of antinuclear antibodies upon isoniazid treatment, Arthritis Rheum, 14, 748, 10.1002/art.1780140610 · doi:10.1002/art.1780140610
- Mitchell, 1975, Metabolic activation of drugs to toxic substances, Gastroenterology, 68, 392, 10.1016/S0016-5085(75)80025-4 · DOI · Paper page
- Mitchell JR, Thorgeirsson UP, Black M, et al. Correlation of rapid acetylator phenotype and isoniazid hepatitis. Possible explanation by analysis of urinary metabolites of isoniazid. In press, Clin Pharmacol Ther
- Rao, 1970, Sulphadimidine acetylation test for classification of patients as slow or rapid inactivators of isoniazid, Br Med J, 3, 495, 10.1136/bmj.3.5721.495 · doi:10.1136/bmj.3.5721.495
- Peters, 1965, Studies on the metabolic basis for the genetically determined capacities for isoniazid inactivation in man, J Pharmacol Exp Ther, 150, 298
- Druckrey, 1973, Specific carcinogenic and teratogenic effects of indirect alkylating methyl and ethyl compounds, and their dependency on stages of ontogenic development, Xenobiotica, 3, 271, 10.3109/00498257309151524 · DOI
- Snodgrass, 1974, Possible mechanism of isoniazid-related hepatic injury, Clin Res, 22, 323A
- Scott, 1969, The discrimination of phenotypes for rate disappearance of isonicotinoyl hydrazide from serum, J Clin Invest, 48, 1173, 10.1172/JCI106081 · doi:10.1172/jci106081
Cited by
(1979) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60848-9 · Cited by 1,163
Isoniazid Liver Injury: Clinical Spectrum, Pathology, and Probable Pathogenesis
MITCHELL, J. R., ZIMMERMAN, H. J., ISHAK, K. G., THORGEIRSSON, U. P., TIMBRELL, J. A., SNODGRASS, W. R., & NELSON, S. D. (1976) · Annals of Internal Medicine · doi:10.7326/0003-4819-84-2-181 · Cited by 505
Self-citationToxic Hepatitis with Isoniazid and Rifampin
Steele, M. A., Burk, R. F., & DesPrez, R. M. (1991) · Chest · doi:10.1378/chest.99.2.465 · Cited by 437
Isoniazid-Associated Hepatitis in 114 Patients
Black, M., Mitchell, J. R., Zimmerman, H. J., Ishak, K. G., & Epler, G. R. (1975) · Gastroenterology · doi:10.1016/s0016-5085(19)32568-5 · Cited by 370
Self-citationAASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury
Fontana, R. J., Liou, I., Reuben, A., Suzuki, A., Fiel, M. I., Lee, W., & Navarro, V. (2023) · Hepatology · doi:10.1002/hep.32689 · Cited by 340
Adverse reactions to first-line antituberculosis drugs
Forget, E. J., & Menzies, D. (2006) · Expert Opinion on Drug Safety · doi:10.1517/14740338.5.2.231 · Cited by 315
Pathogenesis of Idiosyncratic Drug-Induced Liver Injury and Clinical Perspectives
Fontana, R. J. (2014) · Gastroenterology · doi:10.1053/j.gastro.2013.12.032 · Cited by 313
Central role of mitochondria in drug-induced liver injury
Pessayre, D., Fromenty, B., Berson, A., Robin, M.-A., Lettéron, P., Moreau, R., & Mansouri, A. (2012) · Drug Metabolism Reviews · doi:10.3109/03602532.2011.604086 · Cited by 277
CSH guidelines for the diagnosis and treatment of drug-induced liver injury
Drug-induced Liver Injury (DILI) Study Group, Yu, Y.-C., Chinese Society of Hepatology (CSH), Chinese Medical Association (CMA), Mao, Y.-M., Chen, C.-W., Chen, J.-J., Chen, J., Cong, W.-M., Ding, Y., et al. (2017) · Hepatology International · doi:10.1007/s12072-017-9793-2 · Cited by 254
Mechanisms of immune checkpoint inhibitor-mediated liver injury
Shojaie, L., Ali, M., Iorga, A., & Dara, L. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.10.003 · Cited by 98
Serum biomarkers of drug‐induced liver injury: Current status and future directions
Church, R. J., & Watkins, P. B. (2019) · Journal of Digestive Diseases · doi:10.1111/1751-2980.12684 · Cited by 27
Affleck, A., Jackson, D., Williams, H. C., Chavez, P., & Albrecht, J. (2022) · British Journal of Dermatology · doi:10.1111/bjd.21840 · Cited by 17
Metadata
- Authors
- Mitchell, J. R., Long, M. W., Thorgeirsson, U. P., & Jollow, D. J.
- Venue
- Chest
- Publisher
- Elsevier BV
- Published
- 1975-08
- Volume
- 68
- Issue
- 2
- Pages
- 181-190
- ISSN
- 0012-3692
- Cited by
- 95
- References
- 0
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.